Our Leadership
Our Story > Leadership
Global Solutions Team
Our leadership team has the extensive specialty and rare disease, market access, marketing and financial expertise needed to provide a consultative approach for branded specialty products to be brought to market successfully.
Dea Belazi
Chief Executive Officer
Dea brings to AscellaHealth over two decades of impressive leadership and C-level management experience within the healthcare industry and is responsible for the development of PerformRx, a PBM owned by Keystone First Health Plan and Future Scripts, an Independence Blue Cross company sold to Catamaran. Dea was selected as a 2021 Most Admired CEO Honoree by the Philadelphia Business Journal and a 2022 and 2023 Titan 100 Honoree.
Bill Oldham
Chairman & President
Bill is Founder of Oldham Global, a focused investment company building solutions in FinTech, health IT, and health services. Most impressively under Bill’s leadership, AscellaHealth has experienced a 1556% revenue growth over the last 4 years attributed to both organic growth and acquisitions. Bill was selected as a 2022 CFO of the Year Honoree by the Philadelphia Business Journal and a 2023 Titan 100 Honoree.
Mario Patone
Chief Financial Officer
John Campolongo
Chief Operating Officer
Lisa Crowley
Chief of Staff
Andy Szczotka
Chief Pharmacy Officer
Craig Caceci
Executive Vice President / Managing Director, EU/UK
Donovan Quill
Executive Vice President, Growth & Strategy
Denise Cubbin
Senior Vice President, Operations
Erik Reaveley
Executive Vice President, Channel & Strategic Planning
AscellaHealth transforms Specialty Pharmacy with a technology driven platform for ground-breaking, end-to-end solutions which deliver value and elevate the therapy journey for specialty and rare disease patients.
Awards and Accolades
AscellaHealth is proud to be recognized as a leading global specialty pharmacy and healthcare services organization. We have won multiple awards both within and outside of the healthcare industry.